Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1
Award Notice Posted
- Solicitation number
- 75N93024C00019
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Neovaxsyn Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93024C00019 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Ames, Iowa 50014, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, has awarded contract 75N93024C00019 to NeoVaxSyn Inc. for a nanovaccine research project targeting HIV-1. The contract, valued at $2,000,000, will support research focused on developing a vaccine capable of eliciting broadly neutralizing antibodies against HIV-1. The period of performance spans from July 1, 2024, through June 30, 2027, with work to be conducted at NeoVaxSyn's facility in Ames, Iowa. The contract was set aside for small businesses and falls under the NAICS code 541715 for research and development in physical, engineering, and life sciences.
Notice text
Awarded contract 75N93024C00019 to NEOVAXSYN INC for 2000000.00 on 2024-06-25.
Files
| File | Type | Posted |
|---|---|---|
| Award Synopsis NeoVaxSyn.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1 | Award Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity